Home > News > Zyvex Continues to Exceed Sales Expectations
January 26th, 2005
Zyvex Continues to Exceed Sales Expectations
Zyvex today announced financial results for its fiscal 2004 fourth quarter. The Texas company continues its business gains with nine consecutive quarters of sales growth and expansion of its global sales reach.
Total revenue for the fourth quarter was $4.0 million, which was a 55 percent increase over the same period in 2003.
The total revenue for 2004 was $8.6 million, which represented a 102 percent increase over 2003. International sales, new to the company during 2004, accounted for 10 percent of the year’s revenue.
More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014
High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014
INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014
Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their March 17th, 2014
Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014
Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014